Yvonne Parker
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism 2
- Cell Biology top 10%
- Endoplasmic Reticulum Stress and Disease 2
- Hematology top 10%
- Acute Myeloid Leukemia Research 5
-
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3
-
- Epigenetics and DNA Methylation 4
- RNA modifications and cancer 2
-
- Renal cell carcinoma treatment 2
-
- Ovarian cancer diagnosis and treatment 2
- Co-authors
- Daniel J. LindnerMaryam Zamanian-DaryoushEdward A. FisherZeneng WangStanley L. HazenJoseph A. DiDonatoJennifer A. BuffaPatricia Parsons‐Wingerter
- Cited by
- Cancer ResearchCell BiologyOncology
- Journals
- Journal of Biological Chemistry (1 paper)Journal of Clinical Oncology (1 paper)Blood (4 papers)
- Partner nations
- United StatesJapanGermany
In The Last Decade
Yvonne Parker
23 papers receiving 728 citations
Peers
Comparison fields: 5 of 69
- Cancer Research 223
- Cell Biology 124
- Oncology 194
- Hematology 79
- Genetics 63
Countries citing papers authored by Yvonne Parker
This map shows the geographic impact of Yvonne Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yvonne Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yvonne Parker more than expected).
Fields of papers citing papers by Yvonne Parker
This network shows the impact of papers produced by Yvonne Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yvonne Parker. The network helps show where Yvonne Parker may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yvonne Parker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 23 | |
| 5 | 2021 | 15 | |
| 6 | 2020 | 8 | |
| 7 | 2020 | 10 | |
| 8 | 2019 | 1 | |
| 9 | 2018 | 1 | |
| 10 | 2018 | 4 | |
| 11 | 2017 | 55 | |
| 12 | 2017 | 12 | |
| 13 | 2016 | 82 | |
| 14 | 2016 | 39 | |
| 15 | 2016 | 2 | |
| 16 | 2014 | 58 | |
| 17 | 2014 | 47 | |
| 18 | 2014 | 17 | |
| 19 | 2013 | 76 | |
| 20 | 2013 | 198 |
About Yvonne Parker
Yvonne Parker is a scholar working on Hematology, Immunology and Allergy and Genetics, having authored 24 papers that have together received 734 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (5 papers), Epigenetics and DNA Methylation (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Renal cell carcinoma treatment (2 papers), Endoplasmic Reticulum Stress and Disease (2 papers), Cancer, Lipids, and Metabolism (2 papers), Ovarian cancer diagnosis and treatment (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Cancer Research (223 citations), Cell Biology (124 citations) and Oncology (194 citations). Yvonne Parker has collaborated with scholars based in United States, Japan and Germany. Frequent co-authors include Daniel J. Lindner, Maryam Zamanian-Daryoush, Edward A. Fisher, Zeneng Wang, Stanley L. Hazen, Joseph A. DiDonato, Jennifer A. Buffa, Patricia Parsons‐Wingerter, Pat Rayman and Denise A. Hatala. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.